Cubist Systematic Strategies’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,560
| Closed | -$4.61M | – | 4424 |
|
|
2023
Q4 | $4.61M | Buy |
+14,560
| New | +$2.83M | 0.03% | 910 |
|
|
2023
Q3 | – | Sell |
-3,239
| Closed | -$702K | – | 4124 |
|
|
2023
Q2 | $702K | Buy |
+3,239
| New | +$694K | ﹤0.01% | 2184 |
|
|
2023
Q1 | – | Sell |
-822
| Closed | -$162K | – | 4608 |
|
|
2022
Q4 | $162K | Sell |
822
-29,312
| -97% | -$6.29M | ﹤0.01% | 3673 |
|
|
2022
Q3 | $6.78M | Buy |
30,134
+21,824
| +263% | +$4.42M | 0.04% | 790 |
|
|
2022
Q2 | $1.05M | Sell |
8,310
-7,562
| -48% | -$869K | 0.01% | 2443 |
|
|
2022
Q1 | $2.01M | Buy |
15,872
+4,173
| +36% | +$470K | 0.02% | 1478 |
|
|
2021
Q4 | $1.53M | Buy |
11,699
+3,638
| +45% | +$470K | 0.01% | 1603 |
|
|
2021
Q3 | $986K | Buy |
8,061
+6,259
| +347% | +$723K | 0.01% | 1540 |
|
|
2021
Q2 | $205K | Sell |
1,802
-443
| -20% | -$51.8K | ﹤0.01% | 2549 |
|
|
2021
Q1 | $270K | Buy |
+2,245
| New | +$254K | ﹤0.01% | 2321 |
|
|
2020
Q4 | – | Sell |
-3,112
| Closed | -$241K | – | 2752 |
|
|
2020
Q3 | $241K | Buy |
3,112
+1,268
| +69% | +$108K | ﹤0.01% | 2061 |
|
|
2020
Q2 | $206K | Buy |
+1,844
| New | +$160K | ﹤0.01% | 2016 |
|
|
2020
Q1 | – | Sell |
-3,845
| Closed | -$290K | – | 2538 |
|
|
2019
Q4 | $290K | Sell |
3,845
-1,858
| -33% | -$81.4K | 0.01% | 1853 |
|
|
2019
Q3 | $93K | Buy |
+5,703
| New | +$111K | ﹤0.01% | 1952 |
|
Other funds holding KRTX
Cubist Systematic Strategies's KRTX Position: Q1 2024 in Review
Cubist Systematic Strategies sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 14,560 shares — an estimated $4.61M sold.
Cubist Systematic Strategies first reported a position in KRTX in Q3 2019 and held it in 14 quarters. The position peaked at $6.78M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Cubist Systematic Strategies reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 14,560 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.61M.
- Cubist Systematic Strategies first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 14 quarters.
- Cubist Systematic Strategies's Karuna Therapeutics, Inc. Common Stock position peaked at $6.78M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.